We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

FDA Approval for Lilly's Gastric Cancer Drug

CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy.
News

New Drug for Common Liver Disease Improves Liver Health

An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
News

'Rewriting' the Way to Make Natural Drug Compounds

Using an organism's own pathway to synthesize potential therapeutics.
News

San Diego Blood Bank Collaborates with Clinical and Translational Research Institute

San Diego Blood Bank CEO, David Wellis PhD joins Executive Committee at CTRI.
News

Catalent Expands Highly Potent and Cytotoxic Clinical Packaging Capabilities

Completion is expected in January 2015.
News

Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement

Contract expansion will include the production of commercial quantities of a second BMS biologic medicine at Lonza’s Portsmouth facility.
News

Irvine Announces the Opening of an Analytical Facility in Hangzhou, China

Newly built facility will expand Irvine's service offerings into the Asian markets.
News

WuXi AppTec Launches Representative Office in Israel

Company forms strategic collaboration with Pontifax.
News

SGS Awarded cGMP Accreditation for New Italian Analytical Laboratory

New lab will focus on analytical quality control testing.
News

New Vaccine Generates Strong Immune Response Against Hepatitis C

A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease.
Advertisement